Microfluidic Devices Capture and Analyze Single Cancer Cells

(PhysOrg.com) -- One of the grand goals in nanotechnology is to develop a single microfluidic device that integrates all of the components needed to perform polymerase chain reaction (PCR)-based nucleic acid analyses. Experts predict that such a device would enable researchers to develop rapid assays for cancer and other life-threatening diseases while a patient is in the doctor’s office.

If you want to include this story in your blog, copy and paste this formatted text: